Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Bladder01:23

Urinary Bladder

The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.

Actas urologicas espanolas·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Related Experiment Video

Updated: May 8, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Bladder cancer in Spain 2011: population based study.

B Miñana, J M Cózar, J Palou

    The Journal of Urology
    |September 3, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Spain has a high incidence of bladder cancer, with an estimated 11,539 new diagnoses annually. Most new cases involve older males presenting with symptoms like hematuria, often diagnosed as high-grade, nonmuscle-invasive tumors.

    Keywords:
    BCBCGBMICISMMCNMIBCSpainTURBTbacillus Calmette-Guérinbladder cancerbody mass indexcarcinoma in situincidencemitomycin Cneoplasm stagingnonmuscle invasive bladder cancertransurethral bladder tumor resectionurinary bladder neoplasms

    More Related Videos

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies
    07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    Culture of Bladder Cancer Organoids as Precision Medicine Tools
    08:39

    Culture of Bladder Cancer Organoids as Precision Medicine Tools

    Published on: December 28, 2021

    Related Experiment Videos

    Last Updated: May 8, 2026

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
    07:34

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

    Published on: November 17, 2023

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies
    07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    Culture of Bladder Cancer Organoids as Precision Medicine Tools
    08:39

    Culture of Bladder Cancer Organoids as Precision Medicine Tools

    Published on: December 28, 2021

    Area of Science:

    • Urology
    • Oncology
    • Epidemiology

    Background:

    • Bladder cancer represents a significant public health concern globally.
    • Understanding regional incidence and patient demographics is crucial for effective healthcare planning.

    Purpose of the Study:

    • To estimate the annual incidence of bladder cancer in Spain.
    • To describe the clinical characteristics of patients diagnosed with bladder cancer within a population-based study.

    Main Methods:

    • A population-based study was conducted in 2011, utilizing the Spanish National Health System structure.
    • Data were collected from a representative sample of 26 public hospitals, covering 10,146,534 inhabitants (21.5% of the Spanish population).

    Main Results:

    • An estimated 11,539 new bladder cancer cases occur annually in Spain.
    • The age-adjusted incidence rate was 20.08 per 100,000 inhabitants.
    • The majority of primary tumors were nonmuscle-invasive (76.7%) but frequently high-grade (43.7%), with macroscopic hematuria being the most common presenting symptom (90.8%).

    Conclusions:

    • Spain exhibits one of the highest bladder cancer incidences in Europe.
    • Primary nonmuscle-invasive bladder cancer cases often involve high-risk patients.
    • The incidence of carcinoma in situ was low in both primary and recurrent cases.